School of Biomedical Sciences, University of Queensland, Brisbane, Australia.
ACS Nano. 2012 Oct 23;6(10):8962-9. doi: 10.1021/nn3029953. Epub 2012 Sep 25.
The binding of fibrinogen to various nanoparticles can result in protein unfolding and exposure of cryptic epitopes that subsequently interact with cell surface receptors. This response is dependent on the size, charge, and concentration of the nanoparticle. Here we examine the binding kinetics of human fibrinogen to negatively charged poly(acrylic acid)-coated gold nanoparticles ranging in size from 7 to 22 nm. These particles have previously been shown to elicit an inflammatory response in human cells. The larger nanoparticles bound fibrinogen with increasing affinity and a slower dissociation rate. Each fibrinogen molecule could accommodate two 7 nm nanoparticles but only one when the diameter increased to 10 nm. Nanoparticles larger than 12 nm bound multiple fibrinogen molecules in a positively cooperative manner. However, in the presence of excess nanoparticle, fibrinogen induced aggregation of the larger particles that could bind more than one protein molecule. This is consistent with interparticle bridging by the fibrinogen. Taken together, these results demonstrate that subtle changes in nanoparticle size can influence protein binding both with the surface of the nanoparticle and within the protein corona.
纤维蛋白原与各种纳米颗粒的结合会导致蛋白质展开,并暴露出随后与细胞表面受体相互作用的隐匿表位。这种反应取决于纳米颗粒的大小、电荷和浓度。在这里,我们研究了人纤维蛋白原与带负电荷的聚(丙烯酸)涂层金纳米颗粒的结合动力学,这些纳米颗粒的大小范围为 7 至 22 纳米。这些颗粒以前被证明会在人类细胞中引起炎症反应。较大的纳米颗粒与纤维蛋白原的结合具有越来越高的亲和力和较慢的解离速率。每个纤维蛋白原分子可以容纳两个 7nm 的纳米颗粒,但当直径增加到 10nm 时只能容纳一个。直径大于 12nm 的纳米颗粒以正协同的方式结合多个纤维蛋白原分子。然而,在存在过量纳米颗粒的情况下,纤维蛋白原诱导较大颗粒的聚集,这些颗粒可以结合多个蛋白质分子。这与纤维蛋白原的颗粒间桥接一致。综上所述,这些结果表明,纳米颗粒大小的微小变化可以影响蛋白质与纳米颗粒表面和蛋白质冠状物内的结合。